Harvard Apparatus Regenerative Technology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Harvard Apparatus Regenerative Technology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2012 to Q3 2024.
  • Harvard Apparatus Regenerative Technology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $562K, a 5.05% increase year-over-year.
  • Harvard Apparatus Regenerative Technology, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $70K, a 95.8% decline from 2019.
  • Harvard Apparatus Regenerative Technology, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $1.65M, a 119% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $562K +$27K +5.05% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $572K +$93K +19.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $560K -$1.28M -69.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q3 2023 $535K +$291K +119% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $479K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.84M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 $244K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2021 -$522K $131K -$134K -50.6% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-13
Q1 2021 -$388K $130K -$458K -77.9% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $70K -$934K +$60.2M +98.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$60.2M $151K -$378K -71.5% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-13
Q2 2020 -$59.8M $265K -$61.7M -99.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $71.4M $588K +$295K +101% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q1 2020 $70M +$69.7M +23791% Feb 1, 2020 Feb 29, 2020 10-Q 2021-08-13
Q4 2019 $1.65M -$61.2M -$61.5M -20905% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-13
Q3 2019 $63.1M $529K +$335K +173% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $62M +$61.8M +32192% Jun 1, 2019 Jun 30, 2019 10-K 2021-04-13
Q2 2019 $62.8M $531K +$339K +177% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $973K $293K +$218K +291% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $755K $294K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $194K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $192K -$14K -6.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $75K -$116K -60.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2017 $194K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $206K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $191K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q3 2013 $220K +$64K +41% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-27
Q3 2012 $156K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.